Increased spontaneous as well as TNF-a-induced and CD95-mediated apoptosis were observed in CD4+ and CD8+ T cells from the cord blood of a patient with Turner's syndrome as compared to normal cord blood. Increased apoptosis was associated with an increased expression of TNFR-1, TNFR-2, and CD95L and decreased expression of cIAP1 and FLIP L . No significant difference was observed in the expression of Bcl-2 family members (Bcl-2, Bax) between Turner's syndrome cord blood and normal cord blood lymphocytes. This study demonstrates that increased apoptosis of T-cell subsets in Turner's syndrome occurs via the death receptor pathway and may play a role in the pathogenesis of immunological defects associated with Turner's syndrome.
Apoptosis is a physiological form of cell death that plays a crucial role in cellular homeostasis. 1 In the immune system, it plays an important role in T-cell development, selection of T-cell repertoire, deletion of self-reactive lymphocytes, cytotoxic effector function of cytotoxic T-cells and natural killer cells, and removal of effector cells following termination of an immune response. [2] [3] [4] [5] [6] Apoptosis is mediated by two distinct pathways, the death receptor pathway [2] [3] [4] [5] and the mitochondrial pathway. [6] [7] [8] The death receptors belong to the tumor necrosis factor receptor (TNFR)/nerve growth factor receptor family and their ligands belong to the TNF family. The two most extensively studied members include TNFR and CD95 receptor. Upon interaction with their ligands, the death receptors undergo oligomerization and their cytoplasmic death domains recruit adapter protein Fas-associated death domain (FADD), which in turn recruits procaspase-8 to form a death-inducing signaling complex (DISC). Procaspase-8 is autolytically cleaved to form an active caspase-8, which is released from the DISC into the cytoplasm to activate effector caspases resulting in the cleavage of a number of structural proteins, enzymes, and transcription factors and culminate in apoptosis.
Turner's syndrome is a disorder of chromosomal defect, which is associated with deficiency of both cellular and humoral immunity. [9] [10] [11] [12] [13] [14] [15] [16] [17] However, the mechanism(s) for the underlying immunodeficiency has not been explored.
In the course of a study of apoptosis of T-cell subsets in normal cord blood, one of the samples showed significantly abnormal results. Later, it was determined by Karyotype analysis that this sample was from a newborn with Turner's syndrome. In this sample, we observed an increased spontaneous as well as death receptor-mediated apoptosis in both CD4+ and CD8+ T cells as compared with normal cord blood. To the best of our knowledge this is the first report of apoptosis in Turner's syndrome.
Results and discussion
In Turner's syndrome, cell-mediated defects include decreased proliferative response to mitogens, recall antigens, and autoantigens, 11, 12, 16 decreased expression of IL-2 receptors, decreased expression of costimulatory molecules on CD4+ T cells, and CD4+ lymphopenia and low CD4+/CD8+ T-cell ratios. 11, [12] [13] [14] [15] [16] In the present neonate with Turner's syndrome, we have also observed decreased proportions of both CD4+ (7.6%) and CD8+ (5.2%) T cells as compared to normal cord blood CD4+ (41.9%) and CD8+ (30.8%) T cells ( Figure 1) . However, the mechanism(s) of cell-mediated immune defects and T-cell lymphopenia in Turner's syndrome has not been explored. Increased apoptosis has been linked to a number of human diseases with T-cell deficiency, many associated with chromosomal defects. [18] [19] [20] Increased spontaneous apoptosis was observed in both CD4+ and CD8+ T cells from cord blood of neonate with Turner's syndrome as compared to control (Figure 2 ). Similar to the DiGeorge syndrome, 18 lymphocyte from Turner's syndrome expressed increased CD95L (34%), which is otherwise lacking from freshly isolated lymphocytes from normal samples ( Figure 3 ) and is expressed only upon activation. 21 It is likely that increased spontaneous apoptosis in Turner's syndrome is because of CD95-CD95L interactions; however, such a mechanism could not be established using blocking peptides because of limitation of the number of cells available.
We have demonstrated an increased anti-CD95-induced apoptosis in DiGeorge syndrome 18 and cartilage hair hypoplasia syndrome, 20 both disorders associated with T-cell defects. In this study, we have also observed increased anti-CD95-induced apoptosis in CD4+ and CD8+ T-cell subsets from Turner's syndrome as compared to control (Figure 4 ). Since CD95 expression in T-cell subsets from Turner's syndrome (CD4+CD95+ 60%, CD8+CD95+ 68%) was similar to that of normal control (CD4+CD95+70%, CD8+CD95+66%), it is likely that increased anti-CD95-induced apoptosis in the Turner's syndrome is because of signal abnormality downstream of CD95 receptors.
FLIP is a member of the family of viral protein vFLIP and a related cellular protein cFLIP contains a death effector domain (DED) that is similar to DED of FADD and procaspase-8. 22, 23 FLIP inhibits apoptosis via interaction with DED of FADD and thereby inhibits recruitment of procaspase-8 to the DISC, and activation of procaspase-8 to active caspase-8. In addition, FLIP provides a survival signal by activating ERK and NFkB. 24 Therefore, we examined the expression of FLIP L by Western blotting and densitometry (normalized for actin loading and presented as OD ratio) in cord blood lymphocytes from Turner's syndrome and control. A markedly decreased expression (50-fold less) of FLIP L was observed in lymphocytes from Turner's syndrome ( Figure 5 ). Therefore, decreased expression of FLIP L may contribute to an increased spontaneous and CD95-mediated apoptosis in Turner's syndrome.
TNF-a-induces its biological effects via TNFR-1 and TNFR-2. TNF-a-induced apoptosis is primarily mediated via TNFR-1 because TNFR-1 contains death domain, whereas TNFR-2 lacks death domain. 25 However, recently it has been shown that TNFR-2 may enhance TNFR-1-mediated apoptosis. 26, 27 In the present study, TNF-a-induced apoptosis was increased in both CD4+ and CD8+ T-cell subsets from Turner's syndrome at 24 h and CD4+ T cells at 48 h as well ( Figure 6 ). Furthermore, the expression of both TNFR-1 and TNFR-2 was increased in both CD4+ and CD8+ T cells ( Figure 7) . Therefore, it is likely that both TNF receptors are involved in increased TNF-a-induced apoptosis in T-cell subsets in Turner's syndrome. Furthermore, decreased expression of FLIP L may also contribute to increased TNa-induced apoptosis in Turner's syndrome because FADD serves as a common conduit for both TNFR-and CD95-mediated apoptosis 6 and FLIP inhibits both TNFRand CD95-mediated apoptosis. 28 Inhibitor of apoptosis proteins (IAPs) are a family of proteins that inhibits apoptosis by inhibiting activation and activity of caspases, especially caspase-3. 29, 30 In this study, we observed decreased expression of cIAP1 (threefold) in Turner's syndrome as compared to the control ( Figure 5 ). As a result of the retrospective nature of this investigation activation of caspases was not studied. cIAPs inhibit caspase-3, and caspase-3 is activated during all forms of caspase-dependent apoptosis; therefore, it is likely that decreased cIAP1 expression may contribute to increased spontaneous apoptosis as well as increased apoptosis mediated via CD95 and TNFR in lymphocytes from Turner's syndrome. Figure 1 Proportions of CD4+ and CD8+ T cells in Turner's syndrome and control. MNCs were incubated with FITC-conjugated anti-CD4 or anti-CD8 monoclonal antibodies and their isotype controls for 30 min on ice. Cells were washed and 10 000 cells were acquired and analyzed by FACScan. Markers were put at the isotype negative control. Figure 2 Spontaneous apoptosis in T-cell subsets in Turner's syndrome and healthy control. MNCs were incubated in a medium containing 10% FBS for 24 and 48 h and apoptosis in CD4+ and CD8+ T-cell subsets was observed by TUNEL assay using dual color analysis with FITCconjugated anti-CD4 and PerCP-conjugated anti-CD8 antibodies and isotype control.
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Mitochondrial pathway is under control of Bcl-2 family of protein; Bax promotes apoptosis, whereas Bcl-2 inhibits apoptosis. 7, 8 The role of Bcl-2 family protein in death receptor pathway is controversial and appears to play a role under certain circumstances and in certain cell types. 31 In the present subject with Turner's syndrome we did not observe any change in the expression of Bcl-2 or Bax ( Figure 5 ), which suggests that the death receptor pathway plays a major role in increased apoptosis in Turner's syndrome lymphocytes.
In summary, these data suggest that increased apoptosis of T-cell subsets may play a significant role in Figure 4 CD95-mediated apoptosis in T-cell subsets in Turner's syndrome and healthy control. MNCs were activated with 50 ng/ml of anti-CD3 monoclonal antibody for 48 h followed by culture in the presence of IL-2 containing medium for an additional 3 days and then incubation with 500 ng/ml anti-CD95 monoclonal antibody for 24 h and 48 h. Apoptosis in CD4+ and CD8+ T-cell subsets was examined by TUNEL assay as described in Figure 2 . Figure 6 TNF-a-induced apoptosis in T-cell subsets in Turner's syndrome and control. Cells were activated and cultures as above (Figure 4) . At the end of culture in IL-2 containing medium, MNCs were activated with 500 ng/ml TNF-a for 24 and 48 h. Apoptosis was measured by TUNEL assay by triple color flow cytometry using FACScan. Figure 7 Expression of TNFR-1 and TNFR-2 on T-cell subsets in Turner's syndrome. MNCs were incubated with antibodies to FITC conjugated anti-CD4 or Per-CP-conjugated anti-CD8 antibodies and antibodies to TNFR-1 or TNFR-2 and isotype controls on ice and positive cells were analyzed using dual color flow cytometry.
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